Publications found:
58,333
Sort by:
Fibrinogen Deficiency (Factor I Deficiency) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF FIBRINOGEN DEFICIENCY (FACTOR I DEFICIENCY) PIPELINE REPORT INCLUDES Panorama of Fibrinogen Deficiency (Factor I Deficiency) pipeline markets including statistics on therapeutic drugs and companies involved Fibrinogen Deficiency (Factor I Deficiency) Pipeline candidates across ...
August 2018
30 pages
Fibrodysplasia Ossificans Progressiva R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA PIPELINE REPORT INCLUDES Panorama of Fibrodysplasia Ossificans Progressiva pipeline markets including statistics on therapeutic drugs and companies involved Fibrodysplasia Ossificans Progressiva Pipeline candidates across various development ...
August 2018
50 pages
Fibromyalgia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF FIBROMYALGIA PIPELINE REPORT INCLUDES Panorama of Fibromyalgia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Fibrosarcoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF FIBROSARCOMA PIPELINE REPORT INCLUDES Panorama of Fibrosarcoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
70 pages
Fibrosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF FIBROSIS PIPELINE REPORT INCLUDES Panorama of Fibrosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
100 pages
Focal Segmental Glomerulosclerosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS PIPELINE REPORT INCLUDES Panorama of Focal Segmental Glomerulosclerosis pipeline markets including statistics on therapeutic drugs and companies involved Focal Segmental Glomerulosclerosis Pipeline candidates across various development ...
August 2018
50 pages
Fragile X Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF FRAGILE X SYNDROME PIPELINE REPORT INCLUDES Panorama of Fragile X Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Fragile X Syndrome Pipeline candidates across various development ...
August 2018
110 pages
Friedreich Ataxia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF FRIEDREICH ATAXIA PIPELINE REPORT INCLUDES Panorama of Friedreich Ataxia pipeline markets including statistics on therapeutic drugs and companies involved Friedreich Ataxia Pipeline candidates across various development ...
August 2018
70 pages
Functional Dyspepsia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF FUNCTIONAL DYSPEPSIA PIPELINE REPORT INCLUDES Panorama of Functional Dyspepsia pipeline markets including statistics on therapeutic drugs and companies involved Functional Dyspepsia Pipeline candidates across various development ...
August 2018
30 pages
Gallbladder Cancer R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF GALLBLADDER CANCER PIPELINE REPORT INCLUDES Panorama of Gallbladder Cancer pipeline markets including statistics on therapeutic drugs and companies involved Gallbladder Cancer Pipeline candidates across various development ...
August 2018
160 pages
Gastric Ulcers R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF GASTRIC ULCERS PIPELINE REPORT INCLUDES Panorama of Gastric Ulcers pipeline markets including statistics on therapeutic drugs and companies involved Gastric Ulcers Pipeline candidates across various development ...
August 2018
40 pages
Gastritis (stomach inflammation) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF GASTRITIS (STOMACH INFLAMMATION) PIPELINE REPORT INCLUDES Panorama of Gastritis (stomach inflammation) pipeline markets including statistics on therapeutic drugs and companies involved Gastritis (stomach inflammation) Pipeline candidates across various development ...
August 2018
40 pages
Gastroenteritis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF GASTROENTERITIS PIPELINE REPORT INCLUDES Panorama of Gastroenteritis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Gaucher Disease R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF GAUCHER DISEASE PIPELINE REPORT INCLUDES Panorama of Gaucher Disease pipeline markets including statistics on therapeutic drugs and companies involved Gaucher Disease Pipeline candidates across various development ...
August 2018
50 pages
Gaucher Disease Type III R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF GAUCHER DISEASE TYPE III PIPELINE REPORT INCLUDES Panorama of Gaucher Disease Type III pipeline markets including statistics on therapeutic drugs and companies involved Gaucher Disease Type III Pipeline candidates across ...
August 2018
30 pages
Genital Herpes R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF GENITAL HERPES PIPELINE REPORT INCLUDES Panorama of Genital Herpes pipeline markets including statistics on therapeutic drugs and companies involved Genital Herpes Pipeline candidates across various development ...
August 2018
70 pages
Gingivitis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF GINGIVITIS PIPELINE REPORT INCLUDES Panorama of Gingivitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Gliosarcoma R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF GLIOSARCOMA PIPELINE REPORT INCLUDES Panorama of Gliosarcoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
210 pages
Globoid Cell Leukodystrophy (Krabbe Disease) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF GLOBOID CELL LEUKODYSTROPHY (KRABBE DISEASE) PIPELINE REPORT INCLUDES Panorama of Globoid Cell Leukodystrophy (Krabbe Disease) pipeline markets including statistics on therapeutic drugs and companies involved Globoid Cell Leukodystrophy (Krabbe Disease) Pipeline candidates across ...
August 2018
40 pages
Gonorrhea R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF GONORRHEA PIPELINE REPORT INCLUDES Panorama of Gonorrhea pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Gorlin Syndrome (Basal Cell Nevus Syndrome) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF GORLIN SYNDROME (BASAL CELL NEVUS SYNDROME) PIPELINE REPORT INCLUDES Panorama of Gorlin Syndrome (Basal Cell Nevus Syndrome) pipeline markets including statistics on therapeutic drugs and companies involved Gorlin Syndrome (Basal Cell Nevus Syndrome) Pipeline candidates across ...
August 2018
30 pages
Gouty Arthritis (Gout) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF GOUTY ARTHRITIS (GOUT) PIPELINE REPORT INCLUDES Panorama of Gouty Arthritis (Gout) pipeline markets including statistics on therapeutic drugs and companies involved Gouty Arthritis (Gout) Pipeline candidates across various development ...
August 2018
80 pages
Grass Pollen Allergy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF GRASS POLLEN ALLERGY PIPELINE REPORT INCLUDES Panorama of Grass Pollen Allergy pipeline markets including statistics on therapeutic drugs and companies involved Grass Pollen Allergy Pipeline candidates across various development ...
August 2018
50 pages
Graves Diseases R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF GRAVES DISEASES PIPELINE REPORT INCLUDES Panorama of Graves Diseases pipeline markets including statistics on therapeutic drugs and companies involved Graves Diseases Pipeline candidates across various development ...
August 2018
30 pages
Graves' Ophthalmopathy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF GRAVES' OPHTHALMOPATHY PIPELINE REPORT INCLUDES Panorama of Graves' Ophthalmopathy pipeline markets including statistics on therapeutic drugs and companies involved Graves' Ophthalmopathy Pipeline candidates across various development ...
August 2018
30 pages
Guillain Barre Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF GUILLAIN BARRE SYNDROME PIPELINE REPORT INCLUDES Panorama of Guillain Barre Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Guillain Barre Syndrome Pipeline candidates across various development ...
August 2018
40 pages
Haemophilus influenzae Type B Infections R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF HAEMOPHILUS INFLUENZAE TYPE B INFECTIONS PIPELINE REPORT INCLUDES Panorama of Haemophilus influenzae Type B Infections pipeline markets including statistics on therapeutic drugs and companies involved Haemophilus influenzae Type B Infections Pipeline candidates across ...
August 2018
50 pages
Hairy Cell Leukemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF HAIRY CELL LEUKEMIA PIPELINE REPORT INCLUDES Panorama of Hairy Cell Leukemia pipeline markets including statistics on therapeutic drugs and companies involved Hairy Cell Leukemia Pipeline candidates across various development ...
August 2018
70 pages
Heart Transplant Rejection R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF HEART TRANSPLANT REJECTION PIPELINE REPORT INCLUDES Panorama of Heart Transplant Rejection pipeline markets including statistics on therapeutic drugs and companies involved Heart Transplant Rejection Pipeline candidates across various development ...
August 2018
30 pages
Heavy Metal Poisoning R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF HEAVY METAL POISONING PIPELINE REPORT INCLUDES Panorama of Heavy Metal Poisoning pipeline markets including statistics on therapeutic drugs and companies involved Heavy Metal Poisoning Pipeline candidates across various development ...
August 2018
30 pages
Helicobacter pylori Infections R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF HELICOBACTER PYLORI INFECTIONS PIPELINE REPORT INCLUDES Panorama of Helicobacter pylori Infections pipeline markets including statistics on therapeutic drugs and companies involved Helicobacter pylori Infections Pipeline candidates across various development ...
August 2018
60 pages
Hematopoietic Stem Cell Transplantation (HSCT) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) PIPELINE REPORT INCLUDES Panorama of Hematopoietic Stem Cell Transplantation (HSCT) pipeline markets including statistics on therapeutic drugs and companies involved Hematopoietic Stem Cell Transplantation (HSCT) Pipeline candidates across ...
August 2018
70 pages
Hemochromatosis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF HEMOCHROMATOSIS PIPELINE REPORT INCLUDES Panorama of Hemochromatosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Hemophilia A R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... VPA Research with comprehensive information of Hemophilia A pipeline products. The Hemophilia A pipeline guide presents complete overview of drugs ... and ready to use format. SCOPE OF HEMOPHILIA A PIPELINE REPORT INCLUDES Panorama of Hemophilia A pipeline markets including statistics on therapeutic drugs and ...
August 2018
150 pages
Hemophilia B R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... VPA Research with comprehensive information of Hemophilia B pipeline products. The Hemophilia B pipeline guide presents complete overview of drugs ... and ready to use format. SCOPE OF HEMOPHILIA B PIPELINE REPORT INCLUDES Panorama of Hemophilia B pipeline markets including statistics on therapeutic drugs and ...
August 2018
100 pages
Hemorrhage R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... is presented in user friendly and ready to use format. SCOPE OF HEMORRHAGE PIPELINE REPORT INCLUDES Panorama of Hemorrhage pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Hepatic Colorectal Metastasis R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... comprehensive information of HepaticColorectal Metastasis pipeline products. The HepaticColorectal Metastasis pipeline guide presents complete ... use format. SCOPE OF HEPATIC%LI%COLORECTAL METASTASIS PIPELINE REPORT INCLUDES Panorama of HepaticColorectal Metastasis pipeline markets including statistics on ...
August 2018
30 pages
Hepatic Encephalopathy R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF HEPATIC ENCEPHALOPATHY PIPELINE REPORT INCLUDES Panorama of Hepatic Encephalopathy pipeline markets including statistics on therapeutic drugs and companies involved Hepatic Encephalopathy Pipeline candidates across various development ...
August 2018
50 pages
Hepatic Insufficiency R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF HEPATIC INSUFFICIENCY PIPELINE REPORT INCLUDES Panorama of Hepatic Insufficiency pipeline markets including statistics on therapeutic drugs and companies involved Hepatic Insufficiency Pipeline candidates across various development ...
August 2018
60 pages
Hepatitis A R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... from VPA Research with comprehensive information of Hepatitis A pipeline products. The Hepatitis A pipeline guide presents complete overview of drugs ... and ready to use format. SCOPE OF HEPATITIS A PIPELINE REPORT INCLUDES Panorama of Hepatitis A pipeline markets including statistics on therapeutic drugs and ...
August 2018
20 pages
Hepatitis C R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... from VPA Research with comprehensive information of Hepatitis C pipeline products. The Hepatitis C pipeline guide presents complete overview of drugs ... and ready to use format. SCOPE OF HEPATITIS C PIPELINE REPORT INCLUDES Panorama of Hepatitis C pipeline markets including statistics on therapeutic drugs and ...
August 2018
340 pages
Hepatitis D R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... from VPA Research with comprehensive information of Hepatitis D pipeline products. The Hepatitis D pipeline guide presents complete overview of drugs ... and ready to use format. SCOPE OF HEPATITIS D PIPELINE REPORT INCLUDES Panorama of Hepatitis D pipeline markets including statistics on therapeutic drugs and ...
August 2018
50 pages
Hereditary Angioedema R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF HEREDITARY ANGIOEDEMA PIPELINE REPORT INCLUDES Panorama of Hereditary Angioedema pipeline markets including statistics on therapeutic drugs and companies involved Hereditary Angioedema Pipeline candidates across various development ...
August 2018
70 pages
Herpes Labialis (Oral Herpes) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... format. SCOPE OF HERPES LABIALIS (ORAL HERPES) PIPELINE REPORT INCLUDES Panorama of Herpes Labialis (Oral Herpes) pipeline markets including statistics on therapeutic drugs and companies involved Herpes Labialis (Oral Herpes) Pipeline candidates across ...
August 2018
30 pages
Herpes Zoster (Shingles) R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF HERPES ZOSTER (SHINGLES) PIPELINE REPORT INCLUDES Panorama of Herpes Zoster (Shingles) pipeline markets including statistics on therapeutic drugs and companies involved Herpes Zoster (Shingles) Pipeline candidates across various development ...
August 2018
40 pages
Heterozygous familial hypercholesterolemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PIPELINE REPORT INCLUDES Panorama of Heterozygous familial hypercholesterolemia pipeline markets including statistics on therapeutic drugs and companies involved Heterozygous familial hypercholesterolemia Pipeline candidates across various ...
August 2018
40 pages
Hidradenitis Suppurativa R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... to use format. SCOPE OF HIDRADENITIS SUPPURATIVA PIPELINE REPORT INCLUDES Panorama of Hidradenitis Suppurativa pipeline markets including statistics on therapeutic drugs and companies involved Hidradenitis Suppurativa Pipeline candidates across various development ...
August 2018
80 pages
Homozygous Familial Hypercholesterolemia R&D Pipeline Analysis Report, H2-2018
US$ 1,980.00
... use format. SCOPE OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PIPELINE REPORT INCLUDES Panorama of Homozygous Familial Hypercholesterolemia pipeline markets including statistics on therapeutic drugs and companies involved Homozygous Familial Hypercholesterolemia Pipeline candidates across various development ...
August 2018
80 pages
